Miltefosine for Children With PKDL

NCT02193022 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Post Kala Azar Dermal Leishmaniasis

Interventions

DRUG: Miltefosine

Sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh

Collaborators

[object Object]